6:10 PM
 | 
Aug 02, 2007
 |  BC Extra  |  Company News

Axcan submits Ultrase NDA

Axcan (TSX:AXP; AXCA) completed submission of an NDA for Ultrase to treat exocrine...

Read the full 52 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >